District Judge Dismisses Securities Class Action Against Novan, Inc. Relating To Disclosure of FDA Recommendations About Clinical Trials (JSON)

lexblog.com/lib/BDTPXQPPview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "District Judge Dismisses Securities Class Action Against Novan, Inc. Relating To Disclosure of FDA Recommendations About Clinical Trials",
    "url": "https://www.lexblog.com/2019/01/29/district-judge-dismisses-securities-class-action-against-novan-inc-relating-to-disclosure-of-fda-recommendations-about-clinical-trials/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-BDTPXQPP",
        "url": "https://www.lexblog.com/lib/BDTPXQPP/"
    },
    "datePublished": "2019-01-29T10:04:01-05:00",
    "dateModified": "2021-11-08T09:51:45-05:00",
    "author": {
        "@type": "Person",
        "name": "Gregg Weiner, Adam Harris, Abraham Lee"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Ropes & Gray"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Life Sciences Securities Litigation",
    "about": "Banking, Finance and Securities",
    "sourceUrl": "http://lifescienceslitigation.ropesgrayblogs.com/?p=1967",
    "sourceStability": "may-move"
}